Senol Esin, Azap Alpay, Sayin Kutlu Selda, Kutlu Murat, Erbay Ayse, Kocyigit Pelin, Colgecen Emine, Ozbagcivan Ozlem, Ilter Nilsel, Yetkin Funda, Sener Serpil, Mutlu Birsen, Kiran Rebiay, Saltoglu Nese, Engin Burhan, Dinleyici Ener Cagri
Department of Infectious Diseases, Faculty of Medicine, Gazi University, Ankara 06500, Türkiye.
Department of Infectious Diseases, Faculty of Medicine, Ankara University, Ankara 06230, Türkiye.
Infect Dis Rep. 2025 Jun 11;17(3):68. doi: 10.3390/idr17030068.
Over the past few decades, the rising incidence of herpes zoster (HZ) rates appears to have been a global phenomenon. In Türkiye, there is a lack of comprehensive studies addressing the HZ burden of disease, risk factors, and clinical characteristics. The aim of the VARICOMP-Adult study was to evaluate the clinical and demographic findings of adult patients with HZ. We enrolled the medical records of 1955 patients, 1010 females and 945 males, aged between 18 and 97 years between 2009 and 2014. The presence of underlying conditions was present in 35.5% of patients and 345 patients (17.6%) had immunosuppression; 18.0% of patients required hospitalization. The mean age, the presence of underlying conditions, and immunosuppression in hospitalized cases with HZ were higher than those in outpatients. Logistic regression analysis revealed the following risk factors for hospitalization: age, immunosuppression, hypertension, hematological disorders, transplantation, COPD, and the presence of HZ opthalmicus or disseminated disease. We observed seven HZ cases with mortality aged between 58 and 80 years, and all cases had an underlying condition; 9.9% of the entire population reported postherpetic neuralgia (PHN), and age and no previous antiviral medications were the risk factors for PHN. This is the largest nationwide study of adult patients with HZ. Effective healthcare interventions such as antiviral therapy and immunization could prove beneficial in combating disease and treating HZ complications, especially in the high-risk population and individuals of older ages.
在过去几十年中,带状疱疹(HZ)发病率上升似乎是一个全球现象。在土耳其,缺乏针对HZ疾病负担、危险因素和临床特征的全面研究。VARICOMP-成人研究的目的是评估成年HZ患者的临床和人口统计学发现。我们收集了2009年至2014年间1955例患者的病历,其中女性1010例,男性945例,年龄在18至97岁之间。35.5%的患者存在基础疾病,345例患者(17.6%)有免疫抑制;18.0%的患者需要住院治疗。HZ住院病例的平均年龄、基础疾病的存在情况和免疫抑制情况均高于门诊患者。逻辑回归分析揭示了以下住院风险因素:年龄、免疫抑制、高血压、血液系统疾病、移植、慢性阻塞性肺疾病(COPD)以及眼部带状疱疹或播散性疾病的存在。我们观察到7例HZ死亡病例,年龄在58至80岁之间,所有病例均有基础疾病;9.9%的总人口报告有带状疱疹后神经痛(PHN),年龄和未使用过抗病毒药物是PHN的风险因素。这是全国范围内针对成年HZ患者的最大规模研究。抗病毒治疗和免疫接种等有效的医疗干预措施可能有助于对抗疾病和治疗HZ并发症,特别是在高危人群和老年个体中。